Bristol Heart Institute & School of Cellular and Molecular Medicine, University of Bristol, Bristol, United Kingdom.
Thromb Res. 2013 Aug;132(2):e145-51. doi: 10.1016/j.thromres.2013.07.006. Epub 2013 Jul 30.
Viscoelastometry enables rapid evaluation of coagulopathy in settings such as cardiac surgery but may be influenced by red cell concentration.
In order to study the effects of supra-physiological red cell concentrations on viscoelastometry, we compared ROTEM® viscoelastometry and plasma coagulation assay results in high haematocrit (HCT; 0.55-0.76 L/L) blood from patients with cyanotic congenital heart disease (CCHD), and in model high HCT blood (HCT 0.45-0.70 L/L).
High HCT blood from CCHD patients (median HCT 0.66 L/L) displayed prolonged clot initiation in the EXTEM® test compared to controls and reduced maximum clot firmness (MCF) in the EXTEM (median 51 mm vs 64 mm in controls) and FIBTEM® (7 mm vs 14 mm) tests. The plasma fibrinogen (Clauss; CF) was similar in CCHD blood to controls (median 2.94 g/L vs 2.49) but the whole blood fibrinogen concentration (WBFC) was reduced (1.27 g/L vs 1.58). The FIBTEM MCF correlated linearly with the CF (r(2)=0.68; p<0.0001) and WBFC (r(2)=0.65; p<0.0001) in control blood but this relationship was maintained only with WBFC in CCHD blood. Model high HCT blood showed abnormal ROTEM test results that were similar to CCHD blood, including reduced FIBTEM MCF (14 mm with HCT 0.32-0.44 vs 6mm with HCT 0.63-0.70). The ROTEM results were HCT dependent but independent of plasma clotting times and fibrinogen concentration.
Supra-physiologic HCT causes abnormal ROTEM test results consistent with increased dilution of fibrinogen and coagulation factors in whole blood by red cells. High HCT should be considered during interpretation of ROTEM test results in clinical settings.
黏弹性测定法可在心脏手术等情况下快速评估凝血功能障碍,但可能受到红细胞浓度的影响。
为了研究超生理红细胞浓度对黏弹性测定法的影响,我们比较了高红细胞比容(HCT;0.55-0.76L/L)的紫绀型先天性心脏病(CCHD)患者血液与模型高 HCT 血液(HCT 0.45-0.70L/L)的 ROTEM®黏弹性测定法和血浆凝血检测结果。
与对照相比,CCHD 患者的高 HCT 血液(中位 HCT 为 0.66L/L)在 EXTEM®试验中显示出凝血启动时间延长,并且 EXTEM(中位 51mm 与对照 64mm)和 FIBTEM®(7mm 与对照 14mm)试验中的最大血凝块硬度(MCF)降低。CCHD 血液中的血浆纤维蛋白原(Clauss;CF)与对照相似(中位数 2.94g/L 与 2.49),但全血纤维蛋白原浓度(WBFC)降低(1.27g/L 与 1.58)。FIBTEM MCF 与对照血液中的 CF(r(2)=0.68;p<0.0001)和 WBFC(r(2)=0.65;p<0.0001)呈线性相关,但这种关系仅在 CCHD 血液中与 WBFC 保持一致。模型高 HCT 血液显示异常的 ROTEM 试验结果与 CCHD 血液相似,包括 FIBTEM MCF 降低(HCT 0.32-0.44 时为 14mm,HCT 0.63-0.70 时为 6mm)。ROTEM 结果与 HCT 相关,但与血浆凝血时间和纤维蛋白原浓度无关。
超生理 HCT 导致 ROTEM 试验结果异常,这与全血中红细胞对纤维蛋白原和凝血因子的稀释作用一致。在临床环境中解释 ROTEM 试验结果时应考虑高 HCT。